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Caesarean section wound infiltration with local anaesthetic 
for postoperative pain relief – any benefit?
Anthony Akinloye Bamigboye, George Justus Hofmeyr
Delivery by caesarean section (CS) is becoming more frequent 
and is one of the most common major operative procedures 
performed worldwide.  In the USA a CS rate of 26% for all 
births is reported.1 The rate approaches 25% in Canada and 
is over 20% in England, Wales and Northern Ireland.2 In the 
private health sector in South Africa, one study noted a much 
higher figure of 57%.3
Childbirth is an emotional experience for a woman and 
her family. The mother needs to bond with the new baby as 
early as possible and initiate early breastfeeding, which helps 
to contract the uterus and accelerates the process of uterine 
involution in the postpartum period.4 Any form of intervention 
that leads to improvement in pain relief can positively impact 
on early breastfeeding. Prompt and adequate postoperative 
pain relief is therefore an important component of caesarean 
delivery that can make the period immediately after the 
operation less uncomfortable and more emotionally gratifying. 
Postoperative pain after CS is usually managed with opioids in 
combination with other forms of analgesics. 
CS is performed under spinal anaesthesia, spinal epidural, 
epidural block or general anaesthesia. Short- or medium-
acting sedatives, narcotics and local anaesthesia have been 
employed during the operation as an adjunct to anaesthesia 
or to alleviate postoperative pain. Local anaesthetics cause 
reversible blockade of impulse propagation along the nerve 
fibres by preventing the influx of sodium ions through the cell 
membrane of the fibres. Several studies have reported on use of 
pre-emptive local anaesthetics (local anaesthetic given during 
the operation to prevent or reduce pain afterwards) to relieve 
postoperative pain, with results ranging from being beneficial5,6 
to conferring no benefit.7,8 
The local anaesthetic may be administered by pre- or post-
incisional abdominal nerve block (local anaesthetic injected 
to block the nerves before cutting the skin at the beginning of 
the operation, or after closing the skin at the end9) or pre- or 
post-incisional abdominal wound infiltration.5,10 It may also 
be administered by continuous wound irrigation.11 Commonly 
used local anaesthetic agents have side-effects, although these 
are very rare, ranging from allergy to cardiovascular and 
central nervous system effects. Local anaesthetics eventually 
get absorbed systemically and secreted in breastmilk, but their 
effects on breastfed babies have not yet been documented. This 
is in sharp contrast to morphine or pethidine, both of which 
have significant transfer to breastmilk and may have a sedative 
effect on the baby.4     
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Delivery by caesarean section (CS) is becoming more frequent. 
Childbirth is an emotion-filled event, and the mother needs to 
bond with her baby as early as possible. Any intervention that 
leads to improvement in pain relief is worthy of investigation. 
Local anaesthetics have been employed as an adjunct to 
other methods of postoperative pain relief, but reports on 
the effectiveness of this strategy are conflicting. This review 
attempted to assess the effects of local anaesthetic agent 
wound infiltration and/or abdominal nerve blocks on pain 
after CS and the mother’s well-being and interaction with her 
baby.
Methods. We searched the Cochrane Pregnancy and Childbirth 
Group’s Trials Register (April 2009).The selection criteria were 
randomised controlled trials of local analgesia during CS to 
reduce pain afterwards. Twenty studies (1 150 women) were 
included. 
Results. Women who had wound infiltration after CS 
performed under regional analgesia had a decrease in 
morphine consumption at 24 hours compared with placebo 
(morphine dose -1.70 mg; 95% confidence interval (CI) –2.75 
to –0.94). Women who had wound infiltration and peritoneal 
spraying with local anaesthetic after CS under general 
anaesthesia (1 study, 100 participants) had a reduced need for 
opioid rescue (risk ratio (RR) 0.51; 95% CI 0.38 to 0.69). The 
numerical pain score (0 -10) within the first hour was also 
reduced (mean difference (MD) -1.46; 95% CI –2.60 to –0.32). 
Women with regional analgesia who had local anaesthetic 
and non-steroidal anti-inflammatory cocktail wound 
infiltration consumed less morphine (1 study, 60 participants; 
MD –7.40 mg; 95% CI –9.58 to –5.22) compared with those 
who had local anaesthetic control. Women who had regional 
analgesia with abdominal nerve blocks had decreased opioid 
consumption (4 studies, 175 participants; MD –25.80 mg; 
95% CI –50.39 to –5.37). For outcome in terms of the visual 
analogue pain score (0 - 10) over 24 hours, no advantage 
was demonstrated in the single study of 50 participants who 
had wound infiltration with a mixture of local analgesia and 
narcotics versus local analgesia.
Conclusions. Local anaesthetic infiltration and abdominal 
nerve blocks as adjuncts to regional analgesia and general 
anaesthesia are of benefit in CS by reducing opioid 
consumption. Non-steroidal anti-inflammatory drugs may 
provide additional pain relief.
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It is also important to consider the cost implications of local 
anaesthetic administration. Should it prove to be of benefit, 
the actual cost of the local anaesthetic and the additional time 
needed to carry out the procedure may be justified, considering 
the long-term sequelae of pain and immobility immediately 
after CS.
Objectives 
The objectives of the study were to assess the effects of local 
anaesthetic agent wound infiltration/irrigation and/or 
abdominal nerve blocks on pain relief after CS, on the mother’s 
physical, social and mental well-being, and on her ability to 
meet the physical, psychological and nutritional needs of the 
baby.
Methods 
Prospective randomised controlled trials in women undergoing 
CS, either electively or as an emergency, were considered for 
inclusion in the review.
 The types of interventions that were sought were local 
anaesthetic agent wound infiltration versus placebo/no 
infiltration, ilio-inguinal/iliohypogastric nerve block versus 
placebo/no treatment, local anaesthetic agent versus other 
methods of pain relief, and comparisons of different local 
anaesthetic agent techniques. Outcome measures assessed 
included postoperative pain scores, postoperative analgesia 
requirement, time to first rescue analgesia, postoperative fever, 
duration of CS, onset of mobilisation, onset of breastfeeding, 
duration of breastfeeding, duration of exclusive breastfeeding, 
side-effects of the local anaesthetic, duration of hospital stay, 
postoperative wound infection, women’s satisfaction with 
regard to pain relief, occurrence of postnatal depression 
or neurotic/psychotic disorders, chronic pelvic pain, and 
caregiver satisfaction.
Studies were searched for and identified through  the 
Cochrane Pregnancy and Childbirth Group’s Trials Register 
by contacting the Trials Search Co-ordinator (April 2009). 
Details of the search strategies for CENTRAL and MEDLINE, 
the list of hand-searched journals and conference proceedings, 
and the list of journals reviewed via the current awareness 
service can be found in the ‘Specialized Register’ section in 
the editorial information about the Cochrane Pregnancy and 
Childbirth Group.12 There was no language restriction. We 
assessed for inclusion all potential studies we identified via the 
search strategy, and designed a form to extract data. No major 
discrepancies were identified. We used the Review Manager 
software13 to double-enter all the data, assessed the validity of 
each study using the criteria outlined in the Cochrane Handbook 
for Systematic Reviews of Interventions,14 and described methods 
used for generation of the randomisation sequence for each 
trial. 
For each individual study we described the method used 
to generate allocation sequence in sufficient detail to allow an 
assessment of whether it should produce comparable groups. 
We assessed the method as either adequate (any truly random 
process, e.g. random number table; computer random number 
generator), inadequate (any non-random process, e.g. odd or 
even date of birth; hospital or clinic record number), or unclear. 
Method of allocation concealment (checking for possible 
selection bias), blinding, completeness of data and selective 
reporting bias were all assessed.
We carried out statistical analysis using the Review Manager 
software.13 We used fixed-effect meta-analysis for combining 
data in the absence of significant heterogeneity if trials were 
sufficiently similar. When heterogeneity was found, we used 
random-effects analysis. For dichotomous data, we presented 
results as summary risk ratios (RRs) with 95% confidence 
intervals (CIs), and for continuous data we used the mean 
difference if outcomes were measured in the same way 
between trials. We used the standardised mean difference 
to combine trials that measured the same outcome but used 
different methods.
We applied tests of heterogeneity between trials, if 
appropriate, using the I2 statistic. In the event of significant 
heterogeneity, we used a random-effects meta-analysis as an 
overall summary if we determined that this was appropriate. 
Subgroup analysis was for women who had general 
anaesthesia versus regional analgesia. We excluded studies of 
poor quality (those rating B, C or D) in order to assess for any 
substantive difference to the overall result.
Results 
We identified 40 studies. Twenty studies, involving 1 150 
women, carried out in both developed and developing 
countries and spanning almost two decades, met the inclusion 
criteria (Table I). The outcome of interventions is shown in 
Table II. 
Wound infiltration with local anaesthetics only v. 
control
Women who underwent CS under regional anaesthesia 
and had wound infiltration had a decrease in morphine 
consumption at 24 hours (3 studies, 126 participants; 
standardised mean difference (SMD) –1.70 mg; 95% CI –2.75 
to –0.94) compared with placebo. There was no difference in 
visual analogue pain.
Peritoneal spraying/instillation and abdominal 
wound infiltration involving all layers
Women who underwent CS under general anaesthetic, who 
had the wound infiltrated and peritoneal spraying with local 
anaesthetic (1 study, 100 participants), had a reduced need for 
opioid rescue (RR 0.51; 95% CI 0.38 to 0.69). The numerical 
pain score (0 - 10) within the first hour was reduced (MD –1.46 
mg; 95% CI –2.60 to –0.32).
The amount of oral Tramacet (375 mg paracetamol + 150 mg  
tramadol) consumed was reduced in the local anaesthetic 
group compared with controls who received saline (MD –2.35 
mg; 95% CI –3.62 to –1.08).
Local anaesthetic v. local anaesthetic and non-
steroidal anti-inflammatory drug (NSAID) mixture
Women operated on under regional anaesthesia and who had 
a local anaesthetic and NSAID cocktail wound infiltration 
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Table I. Characteristics of included studies
Author   Methods  Participant  Intervention    Outcome
Bamigboye et al.15  Randomised 100 consenting  50 women received 225 mg  Postoperative
   double-blind,  women, elective CS  ropivacaine if 64 kg or more and pethidine, diclofenac
   placebo-     3 mg/kg if less. Controls received injection and Tramacet
   controlled trial    an equivalent volume of saline. 
        All layers of anterior abdominal
        incision infiltrated, including
        peritoneum
Bell et al.16  Randomised 59 women,   31 women had ilio-inguinal-  Postoperative morphine
   double-blind  randomised  iliohypogastric nerve block with use and visual analogue
   placebo-  to receive nerve  0.5% bupivacaine with adrenaline pain scores
   controlled trial block or saline  and 28 had saline placebo
     placebo
Caulry et al.17  Randomised 30 women, spinal  Wound irrigation in each group Visual analogue pain
   placebo-  anaesthesia, randomised     scores and use of morphine
   controlled trial into 10 each of saline, 
     ropivacaine and
     diclofenac
Chen et al.18  Randomised 36 women, randomised into  Ilio-inguinal nerve block after CS Pain, times of pethidine
   clinical trial 12 no treatment, 12 plain     injection, first time and
     Marcaine and 12 Marcaine     dosage of pethidine
     with adrenaline      injection, postpartum
            haemorrhage and
            uterine atony
Ganta et al.5  Randomised 62 women, elective CS  21 women had bilateral ilioinguinal Visual analogue scale pain
   single-blind  under general anaesthesia nerve block with 0.5% bupivacaine,  scores in first 24 hours and
   placebo-     20 had wound infiltration with 0.5%  mean morphine consumption
   controlled trial    bupivacaine, and 21 received no in 24 hours
        local anaesthetic
Givens et al.11  Randomised  36 women,  planned CS 20 women with wound irrigation Postoperative morphine
   double-blind    with 0.25% bupivacaine v. 16 with  use and visual analogue
   placebo-     normal saline solution irrigation pain scores
   controlled trial
Kumar et al.10  Randomised 50 ASA I and II women, 24 women received pre-incisional Visual analogue pain scores
   controlled trial elective CS  0.5% bupivacaine 40 ml v. 26  at different hours in the first
        receiving bupivacaine 40 ml  24 hours and side-effects of
        and 2 mg morphine mixture  vomiting, nausea and pruritus
Kuppuvelumani et al.19   Randomised  60 women, CS under Mixture of 0.5% bupivacaine with Time to breastfeeding, total
   controlled trial general anaesthesia  adrenaline with 1% xylocaine  pethidine requirement over
        injected to block the ilio-inguinal/ 24 hours and duration of
        iliohypogastric nerve in 30 women action of the block
        v. 30 controls who did not receive
        abdominal nerve block
Lacrosse et al.20  Prospective  55 healthy parturients,  19 women had wound irrigation  Local ropivacaine wound
   randomised trial CS under spinal  with 300 mg diclofenac for 48 hours, infiltration superior to
     anaesthesia  18 had ropivacaine 0.2%, 18  diclofenac only in the first
        controls had saline   24 hours, but diclofenac
            has a better opioid-
            sparing effect
Lanvand’homme et al.21 Randomised 90 women randomly  Continuous wound infiltration Postoperative morphine
   double-blind allocated to receive  with the allocated interventions consumption, parietal and
   placebo-  saline, diclofenac or      visceral visual analogue
   controlled trial 0.2% ropivacaine,       pain scores
     30 in each group
Marbaix et al.22  Randomised 55 healthy parturients,  19 women had wound irrigation Visual analogue pain scores
   prospective trial elective CS under  with 300 mg diclofenac for 48 hours,  and morphine consumption
     spinal anaesthesia  18 had ropivacaine 0.2%, 18 controls
        had saline
 McDonnell et al.23  Randomised  50 women, CS under  1.5 mg/kg ropivacaine per side  Morphine requirement, 
   controlled trial spinal anaesthesia  injected into the transversus  prolonged and superior
        abdominis plane (TAP) versus analgesia up to 36 hours
        saline TAP block   postoperatively
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consumed less morphine in the first 18 hours (1 study, 60 
participants; MD –7.40 mg; 95% CI –9.58 to –5.22) compared 
with controls who received a local anaesthetic only. There was 
no difference in the occurrence of vomiting or reduction in 
anti-emetic use (RR 1.40 mg; 95% CI 0.90 to 2.16).
Anterior abdominal nerve block with local 
anaesthetic v. control
Women who had regional anaesthesia and an abdominal 
nerve block had decreased opioid consumption (4 studies, 175 
participants; MD –25.80 mg; 95% CI –50.39 to –5.37) but no 
difference in visual analogue pain score (0 - 10) (2 studies, 83 
participants; MD  –1.82 (95% CI –2.74 to –0.90)).
Local anaesthetics v. local anaesthetics + narcotics
In terms of the visual analogue scale over 24 hours, no 
advantage was demonstrated in the single study of 50 
participants who had wound infiltration with a mixture of local 
anaesthetic and narcotics versus local anaesthetic.
Local anaesthetics v. local anaesthetics + ketamine
Addition of ketamine to the local anaesthetic in women 
receiving regional anaesthesia does not confer any advantage 
in terms of narcotic consumption or patient satisfaction (1 
study, 50 participants).
Discussion 
Minimising pain after CS is best achieved using a multimodal 
approach. Local anaesthetics, from lidocaine to the more recent 
ropivacaine, have been used as pre-emptive analgesics since 
the 1980s. Clinical trials were only published in the early 
1990s. Local anaesthetic has been used in women receiving 
general anaesthesia and regional anaesthesia, and rarely local 
anaesthesia alone has been used when other anaesthesia 
was unavailable or unsafe. Various routes of administration 
have been tested, such as subcutaneous wound infiltration, 
infiltration through all layers of the abdomen, continuous 
wound instillation or iliohypogastric/ilio-inguinal nerve 
blocks. Ultrasound-guided nerve blocks may soon be explored. 
Local anaesthesia has been used alone and in combination with 
NSAIDs or ketamine.
This review showed that women undergoing CS under 
regional analgesia who had local anaesthetic infiltration or 
abdominal nerve block had a reduced need for postoperative 
opioids. Addition of NSAIDs to the local anaesthetic for 
wound infiltration conferred additional advantage, perhaps 
because these analgesics have a different mode of action. 
Opioid consumption may not be the optimal method of pain 
assessment because of being influenced by patient fear of 
dependency, but this effect is balanced by the randomisation 
Table I. Characteristics of included studies (continued)
Mecklem et al.24  Randomised  79 women, CS under  Patients allocated to receive  Visual analogue pain scores, 
   double-blind spinal analgesia  either saline or 0.25% bupivacaine morphine consumption and
   placebo-         gastro-intestinal side-effects
   controlled trial
Pavy et al.25  Randomised trial 40 women for elective CS 20 patients received 0.5%   Pain scores, pruritus
        bupivacaine, 20 received saline and nausea
Pirbudak et al.26  Randomised  60 women, CS under 40 ml 0.25% bupivacaine + 100 mg  Reduction in postoperative
   double-blind spinal anaesthesia  tramadol + 20 mg tenoxicam v.  analgesic use and prolongation
        normal saline   of analgesic requirement time
Rosaeg et al.27  Randomised  40 women, elective CS  Experimental group received  Visual analogue pain scores
   controlled trial    intrathecal morphine, incisional at rest and at mobilisation. 
        bupivacaine and ibuprofen and Time to first walking, eating, 
        acetaminophen, v. IVI morphine bowel movement and voiding
        weaned to acetaminophen and codeine.
        Both groups received 0.75% 
        bupivacaine spinal analgesia
Solak et al.28  Randomised trial 30 women, elective CS Patients randomised to receive either  Visual analogue pain scale
        20 ml 0.5% bupivacaine or saline scores, analgesic requirement
            and cortisol level
Trotter et al.9  Randomised  28 women, elective CS 0.5% bupivacaine v. saline  Morphine consumption, 
   double-blind trial        pain scores, sedation
            level and nausea
Zohar et al.29  Prospective  50 term parturients,  A multi-holed device was placed Visual analogue scale for pain,
   randomised CS under spinal  in the wound and connected to a rescue morphine,
   double-  anaesthesia  patient-controlled pump.   patient satisfaction
   blind study    Bupivacaine v. bupivacaine
        combined with ketamine
Zohar et al.30  Prospective, 90 parturients   30 women had wound instillation  Rescue analgesic required, 
   randomised,  (ASA 1 & 2), elective CS with 0.25% bupivacaine and 75 mg visual analogue pain scale, 
   double-blind,     intravenous diclofenac via a patient- nausea and patient satisfaction
   placebo-     controlled analgesic infusion pump, 
   controlled trial    30 only bupivacaine instillation, 
        30 only diclofenac infusion
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Table II. Data and analyses  
Outcome or subgroup  Studies  Participants Statistical method      Effect estimate
Wound infiltration with  
local anaesthetic only v. control
Total morphine consumption as  3  126  SMD (IV, random, 95% CI )      –1.72 (–2.35 to –1.09) 
defined by trial author
in the first 24 hours
General anaesthesia  0  0  SMD (IV, random, 95% CI )      Not estimable 
Regional anaesthesia  3  126  SMD (IV, random, 95% CI )      –1.72 (–2.35 to –1.09) 
Visual analogue scale  
(0 - 10) at 24 hours   2  56  MD (IV, fixed, 95% CI)      –0.39 (–1.72 to 0.94) 
Regional anaesthesia  2  56  MD (IV, fixed, 95% CI)      –0.39 (–1.72 to 0.94) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)      Not estimable 
Total morphine consumption  
as defined by trial author,  
in the first 12 hours   1  28  MD (IV, fixed, 95% CI)      –0.39 (–0.68 to –0.10) 
General anaesthesia  1  28  MD (IV, fixed, 95% CI)      –0.39 (–0.68 to –0.10) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)      Not estimable 
Wound infiltration with local  
anaesthetic and peritoneal  
spraying v. placebo
Need for pethidine rescue  
within 1 hour of delivery  1  100  RR (M-H, fixed, 95% CI)      0.51 (0.38 to 0.69) 
General anaesthesia  1  100  RR (M-H, fixed, 95% CI)     0.51 (0.38 to 0.69) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Numerical pain score  
(0 - 10) at 1 hour   1  100  MD (IV, fixed, 95% CI)      –1.46 (–2.60 to –0.32) 
General anaesthesia  1  100  MD (IV, fixed, 95% CI)      –1.46 (–2.60 to –0.32) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)      Not estimable 
Numerical pain score  
(0 - 10) at 8 hours   1  100  MD (IV, fixed, 95% CI)      –0.58 (–3.29 to 2.13) 
General anaesthesia  1  100  MD (IV, fixed, 95% CI)      –0.58 (–3.29 to 2.13) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)      Not estimable 
Numerical pain score at 24 hours 1  97  MD (IV, fixed, 95% CI)      0.19 (–0.67 to 1.05) 
General anaesthesia  1  97  MD (IV, fixed, 95% CI)      0.19 (–0.67 to 1.05) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Total pethidine consumed  
24 hours after delivery  1  97  MD (IV, fixed, 95% CI)      –44.00 (–108.31 to 20.31) 
General anaesthesia  1  97  MD (IV, fixed, 95% CI)     –44.00 (–108.31 to 20.31) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Severe pain 15 minutes after delivery 1  100  RR (M-H, fixed, 95% CI)       0.19 (0.09 to 0.42) 
General anaesthesia  1  100  RR (M-H, fixed, 95% CI)     0.19 (0.09 to 0.42) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Severe pain 2 hours after delivery 1  98  RR (M-H, fixed, 95% CI)     0.31 (0.11 to 0.88) 
General anaesthesia  1  98  RR (M-H, fixed, 95% CI)     0.31 (0.11 to 0.88) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Severe pain 4 hours after delivery 1  98  RR (M-H, fixed, 95% CI)     0.58 (0.28 to 1.19) 
     General anaesthesia  1  98  RR (M-H, fixed, 95% CI)     0.58 (0.28 to 1.19) 
      Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Severe pain (0 - 10) 8 hours  
after delivery   1  100  RR (M-H, fixed, 95% CI)     0.71 (0.35 to 1.45) 
General anaesthesia  1  100  RR (M-H, fixed, 95% CI)     0.71 (0.35 to 1.45) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Severe pain 16 hours after delivery 1  96  Odds ratio (OR) 
        (M-H, fixed, 95% CI)     0.35 (0.11 to 1.11)
General anaesthesia  1  96  OR (M-H, fixed, 95% CI)     0.35 (0.11 to 1.11) 
Regional anaesthesia  0  0  OR (M-H, fixed, 95% CI)     Not estimable 
Severe pain 24 hours after delivery 1  97  RR (M-H, fixed, 95% CI)     0.82 (0.27 to 2.50) 
General anaesthesia  1  97  RR (M-H, fixed, 95% CI)     0.82 (0.27 to 2.50) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Number of Tramacet (375 mg para- 
cetamol + 150 tramadol) tablets used 1  95  MD (IV, fixed, 95% CI)     –2.35 (–3.62 to –1.08) 
General anaesthesia  1  95  MD (IV, fixed, 95% CI)     –2.35 (–3.62 to –1.08) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Amount of rescue diclofenac  
(mg) used during hospitalisation 1  95  MD (IV, fixed, 95% CI)     –43.79 (–66.95 to –20.63) 
General anaesthesia  1  95  MD (IV, fixed, 95% CI)     –43.79 (–66.95 to –20.63) 
Regional anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable
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Table II. Data and analyses (continued)
Wound infiltration with local  
anaesthetic + NSAIDs v. control
No. of attempts to activate PCA  1  60  MD (IV, fixed, 95% CI)     –15.00 (–30.22 to 0.22) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  60  MD (IV, fixed, 95% CI)     –15.00 (–30.22 to 0.22) 
Total morphine (mg)  
used in the first 18 hours  1  60  MD (IV, fixed, 95% CI)     –7.40 (–9.58 to –5.22) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  60  MD (IV, fixed, 95% CI)     –7.40 (–9.58 to –5.22) 
Need for anti-emetic  1  60  RR (M-H, fixed, 95% CI)     0.38 (0.17 to 0.83) 
General anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  60  RR (M-H, fixed, 95% CI)     0.38 (0.17 to 0.83) 
Patient satisfaction good/excellent 1  60  RR (M-H, fixed, 95% CI)     1.26 (1.02 to 1.55) 
General anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  60  RR (M-H, fixed, 95% CI)     1.26 (1.02 to 1.55) 
Nausea    1  40  RR (M-H, fixed, 95% CI)     1.40 (0.90 to 2.16) 
General anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  40  RR (M-H, fixed, 95% CI)     1.40 (0.90 to 2.16) 
Pruritus    1  40  RR (M-H, fixed, 95% CI)     1.81 (1.01 to 3.23) 
General anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  40  RR ( M-H, fixed, 95% CI)     1.81 (1.01 to 3.23) 
Abdominal nerve blocks with  
local anaesthetic v. placebo  
block or no block
Mean visual analogue  
scale at 24 hours   2  83  MD (IV, fixed, 95% CI)     –1.82 (–2.74 to –0.90) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  2  83  MD (IV, fixed, 95% CI)     –1.82 (–2.74 to –0.90) 
Postoperative opioid use (mg),  
as defined by trial authors  4  175  MD (IV, fixed, 95% CI)     –25.80 (–50.39 to –1.21) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  4  175  MD (IV, fixed, 95% CI)     –25.80 (–50.39 to –1.21) 
No. of times mother  
breastfed in 24 hours  1  60  RR (M-H, fixed, 95% CI)     0.20 (0.02 to 1.61) 
General anaesthesia  1  60  RR (M-H, fixed, 95% CI)     0.20 (0.02 to 1.61) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
Wound infiltration with  
local anaesthetic v.  
local anaesthetic + narcotics
Mean visual analogue score  
at 2 hours   1  50  MD (IV, fixed, 95% CI)     0.69 (–0.08 to 1.46) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  50  MD (IV, fixed, 95% CI)     0.69 (–0.08 to 1.46) 
Mean visual analogue score at 12 hours 1  50  MD (IV, fixed, 95% CI)     0.18 (–0.59 to 0.95) 
Regional anaesthesia  1  50  MD (IV, fixed, 95% CI)     0.18 (–0.59 to 0.95) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Mean visual analogue score at 24 hours 1  50  MD (IV, fixed, 95% CI)     –0.15 (–0.92 to 0.62) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  50  MD (IV, fixed, 95% CI)     –0.15 (–0.92 to 0.62) 
Wound infiltration with local  
anaesthetic v. local anaesthetic  
+ ketamine
Total morphine consumed in   
the first 6 hours   1  50  MD (IV, fixed, 95% CI)     0.10 (–2.74 to 2.94) 
General anaesthesia  0  0  MD (IV, fixed, 95% CI)     Not estimable 
Regional anaesthesia  1  50  MD (IV, fixed, 95% CI)     0.10 (–2.74 to 2.94) 
Patient satisfaction good/excellent 1  50  RR (M-H, fixed, 95% CI)     1.20 (0.42 to 3.43) 
General anaesthesia  1  50  RR (M-H, fixed, 95% CI)     1.20 (0.42 to 3.43) 
Regional anaesthesia  0  0  RR (M-H, fixed, 95% CI)     Not estimable 
PCA = patient-controlled analgesia; IV = inverse variance, used when analysis model is random effect; M-H = Mantel-Haenszel statistical method, used when analysis model is fixed 
effect.
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process. Significant results must be regarded with caution 
because of testing at multiple times, and the results are mostly 
based on single trials involving few women. None of the trials 
addressed chronic pelvic pain or cost implications.
Conclusions 
In general, we conclude that local anaesthesia is of benefit in 
women having a CS because it reduces opioid consumption. 
It can be recommended as part of the multimodal approach to 
pain relief, but in terms of affordability a cost-benefit analysis 
is needed as theatre time will be increased and there is a cost 
attached to the local anaesthetic and accessories. This cost 
increase may be offset by less use of postoperative analgesia. 
A pharmacokinetic study of local anaesthetic absorption after 
wound and peritoneal infiltration is necessary. Ultrasound-
guided direct block of the anterior abdominal wall nerves in 
CS should be explored. An important field of investigation will 
also be the effect of the intervention on chronic pelvic pain.
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